Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Workspace Group hikes rents as occupancy falls

(Sharecast News) - Office owner and operator Workspace Group met expectations with its full-year results, with a small increase in income as higher rents made up for falling occupancy levels. Underlying rental income rose 1.7% over the 12 months to 31 March at £135.5m, though net rental come fell 3.2% to £122.1m as a result of £100m-worth of asset disposals during the period.

Like-for-like occupancy stood at just 83.0% during the year, down from 88.0% previously, reflecting a higher-than-usual level of larger customers vacating in the period. However, LFL rents per square foot increased 4.8% to £48.08.

"These challenges will continue in the coming year, but we now have a very clear, deliverable strategy in place to stabilise and rebuild our occupancy and drive rental growth," said chief executive Lawrence Hutchings, who joined the company six months ago.

Workspace's portfolio was valued at £2.37bn by the end of the fiscal year, down 2.4% over the year before.

Trading profit after interest was up 1.2% at £66.8m, while headline pre-tax profit totalled £5.4m, compared with a loss of £192.8m previously. The total dividend was raised to 28.4p from 28.0p.

The stock was down 1.2% at 400.5p by 0830 BST.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.